ERC Starting Grant · 2025
Daily ingestion of nanoparticles (NPs) is inevitable due to their wide use by the food sector, some as bactericidal agents. But their antimicrobial effects towards our gut bacteria remain largely unknown. While some studies investigated their impact on microbial composition, very few explored microbial functional changes and significance for host health. It is alarming that our gut microbiome, unanimously recognized as central in many diseases, is currently overlooked in nanotoxicology. Among key roles of microbiota, we and others underlined that secondary bile acids (BA), generated by the gut bacteria, regulate inflammation in the liver by interacting with host receptors. We showed in mice…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.